Cornell receives almost $2 million from New York state for stem cell research
Cornell University received two one-year institutional development grants for stem cell research from the state of New York as part of $14.5 million in similar awards granted statewide Jan. 7. A grant to Cornell's Ithaca campus totaled $1 million, while a second award for $997,382 was given to the Weill Cornell Medical College in New York City. These are the first grant awards from New York's new $600 million, multiyear stem cell research program that came out of a stem cell research initiative in the 2007-08 state budget.
"This is a major boost for our stem cell programs and will support individual projects, core facilities and collaborative stem cell research on campus," said Michael Kotlikoff, the Austin O. Hooey Dean of Cornell's College of Veterinary Medicine. "The program brings investigators together from several colleges and includes work on stem cell biology and cancer, as well as translational projects using human embryonic stem cell lines in animal models of human disease."
Cornell currently has investigators who conduct research on embryonic and adult stem cells, basic stem cell biology and the use of stem cells to treat cancer, cardiovascular and degenerative disorders. Also, compared to other institutions, Cornell researchers engage in "unparalleled interdisciplinary interactions," and the veterinary college gives Cornell the unique advantage of comparing stem cells across species, as researchers here study mouse, dog, horse and human
stem cells, said Alexander Nikitin, the principal investigator of the grant and associate professor of
pathology in the Department of Biomedical Sciences at the veterinary college.
He said investigators on the Ithaca campus from the Departments of Molecular Biology and Genetics and of Biomedical Engineering will receive the funding. The money will be divided approximately 50 percent for research, 20 percent for training new investigators in stem cell science and 30 percent for acquiring new instruments for conducting research. Some funds also will go toward establishing a Cornell stem cell program that will offer workshops and will invite national and international experts to Cornell to give seminars and training, Alexander Nikitin, the principal investigator of the grant and associate professor of pathology in the Department of Biomedical Sciences at the veterinary college, Nikitin said.
At the Weill Cornell Medical College's Ansary Stem Cell Center for Regenerative Medicine, the state grant will provide scientists and students the funds to examine the prospective uses of both adult stem cells and embryonic stem cells.
Immune cells that process food and bacterial antigens in the intestines control the intestinal population of fungi, according to a new study from Weill Cornell Medicine scientists. Defects in the fungus-fighting abilities of these cells may contribute to some cases of Crohn's disease and ot ... more
For the more than 1 million Americans who live with type 1 diabetes, daily insulin injections are literally a matter of life and death. And while there is no cure, a Cornell University-led research team has developed a device that could revolutionize management of the disease.
In Type 1 dia ... more
Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from pre-existing moles, but the majority of them come from sources unknow ... more
Cornell is a privately endowed research university and a partner of the State University of New York. As the federal land-grant institution in New York State, we have a responsibility—unique within the Ivy League—to make contributions in all fields of knowledge in a manner that prioritizes ... more